Connect to other sites within the UBM Medica Network
Benign Breast Mass Not So Benign After All
New evidence reveals that risk prediction for breast cancer is imperative in women with atypical hyperplasia of breast tissue.
Hypofractionated WBI Slow to Catch On
Despite having advantages over conventional whole breast irradiation, hypofractionated WBI is used by only a third of patients who would benefit.
Tomosynthesis Better Detects Cancer in Dense Breasts
Evidence is mounting that digital tomosynthesis has better cancer detection rates than digital mammography, especially for women with dense breasts.
New Model for Genetic Testing, Breast Cancer Risk
A new (theoretical) model using multiple data points, including genetic testing for BRCA genes, could identify women at greatest risk for breast cancer.
Are Breast Cancer Awareness Campaigns Doing Enough?
Breast cancer awareness campaigns are great, but they should be expanded to provide more clinician education on health disparities and to target women most at risk.
Refined Use of Circulating Tumor Cells in Breast Cancer
Two new publications offer guidance in the use of circulating tumor cells in peripheral blood to monitor treatment efficacy in metastatic and non-metastatic breast cancer.
Blood Test Predicts Breast Cancer Recurrence
A new pilot study demonstrates the ability of a blood-based test to detect metastatic breast cancer recurrence with high sensitivity and specificity.
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.